The SARS-CoV-2 Delta Variant is Poised to Acquire Complete Resistance to Wild-type Spike Vaccines

The study from Japan shows that the injections will be ineffective against the COVID delta variant. The researcher conclude that we should develop more vaccines against emerging variants (apparently they are unaware that safe and effective treatments are available).

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

%d bloggers like this: